KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 117 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $231,000 | -20.3% | 67,981 | -11.8% | 0.00% | – |
| Q2 2018 | $290,000 | -3.0% | 77,085 | +5.4% | 0.00% | – |
| Q1 2018 | $299,000 | -14.3% | 73,150 | -2.7% | 0.00% | – |
| Q4 2017 | $349,000 | -33.1% | 75,179 | +2.2% | 0.00% | -100.0% |
| Q3 2017 | $522,000 | +9.4% | 73,531 | +11.1% | 0.00% | 0.0% |
| Q2 2017 | $477,000 | +21.7% | 66,161 | +4.0% | 0.00% | – |
| Q1 2017 | $392,000 | +19.5% | 63,597 | +13.6% | 0.00% | – |
| Q4 2016 | $328,000 | +9.7% | 55,959 | -0.6% | 0.00% | – |
| Q3 2016 | $299,000 | -19.6% | 56,290 | +0.2% | 0.00% | -100.0% |
| Q2 2016 | $372,000 | +13.4% | 56,181 | -19.3% | 0.00% | – |
| Q1 2016 | $328,000 | -5.7% | 69,626 | +1.3% | 0.00% | – |
| Q4 2015 | $348,000 | +43.8% | 68,766 | 0.0% | 0.00% | – |
| Q3 2015 | $242,000 | -91.3% | 68,766 | -75.4% | 0.00% | -100.0% |
| Q2 2015 | $2,785,000 | -21.7% | 279,020 | -0.1% | 0.00% | -40.0% |
| Q1 2015 | $3,555,000 | +9.1% | 279,212 | +21.2% | 0.01% | 0.0% |
| Q4 2014 | $3,259,000 | -8.5% | 230,317 | -11.0% | 0.01% | 0.0% |
| Q3 2014 | $3,560,000 | -6.9% | 258,898 | +4.1% | 0.01% | -16.7% |
| Q2 2014 | $3,824,000 | +237.8% | 248,635 | +274.3% | 0.01% | +200.0% |
| Q1 2014 | $1,132,000 | +41.3% | 66,427 | +7.3% | 0.00% | +100.0% |
| Q4 2013 | $801,000 | +32.4% | 61,888 | +3.3% | 0.00% | 0.0% |
| Q3 2013 | $605,000 | +37.5% | 59,911 | +1.7% | 0.00% | 0.0% |
| Q2 2013 | $440,000 | – | 58,913 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |